Iterum Therapeutics Financial Overview
Iterum Therapeutics's market cap is currently $16.58M. The company's EPS TTM is $-0.16; its P/E ratio is -0.42; Iterum Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
